Biohit's Financial Reporting and Annual General Meeting in 2015

Biohit Oyj Stock Exchange Release, November 10, 2014 at 2 P.M. local time (EET)

Biohit will release its financial statements for 2014 on Thursday 26th of February 2015 at 9:30 AM.

Biohit Oyj’s Annual General Meeting has been planned for Monday 20th of April 2015 at 3:00 PM local time in Helsinki, Finland. The Board of Directors will call the General Meeting at a later date.

Company will publish three interim reports in 2015, based on the following schedule:

• Interim report for period January - March 2015 (Q1) on Thursday 7th of May 2015 at 9:30 AM.

• Interim report for period January - June 2015 (Q2) on Thursday 20st of August 2015 at 9:30 AM.

• Interim report for period January - September 2015 (Q3) on Thursday 22rd of October 2015 at 9:30 AM.

The published economic reports and other stock exchange releases will be available on Biohit's website at www.biohithealthcare.com/investors. The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at http://www.biohithealthcare.com/investors/stock-exchange-releases/order-releases-to-your-email.

Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com